Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Almirall signs a deliberate agreement with 23andMe to license rights of a bispecific monoclonal antibody designed to blocks all three isoforms of IL-36 cytokine
admin
-
January 10, 2020
0
Latest Pharma-News
Hikma and Arecor announce exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US using Arestat™ technology
admin
-
January 10, 2020
0
Latest Pharma-News
Bayer and Exscientia collaborate to influence the potential of artificial intelligence(AI) in cardiovascular and oncology drug discovery
admin
-
January 10, 2020
0
Latest Pharma-News
FDA approves Blueprint Medicines Ayvakit (avapritinib) ,first targeted therapy to treat a rare mutation in patients with Unresectable or Metastatic PDGFRA Exon 18...
admin
-
January 10, 2020
0
Latest Pharma-News
Daiichi Sankyo ENHERTU® is Now Available in the U.S. for the HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based...
admin
-
January 9, 2020
0
Latest Pharma-News
FDA approves less invasive surgical approach for Abbott’s heart pump in order to help patients avoid Open Heart Surgery
admin
-
January 9, 2020
0
Latest Pharma-News
Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility does not improve pregnancy rates, sperm counts or sperm function
admin
-
January 9, 2020
0
Latest Pharma-News
BMS Completes Divestment of its oral solid, biologics, and sterile product Manufacturing and packaging Facility in Anagni, Italy
admin
-
January 9, 2020
0
Latest Pharma-News
FDA Ok’s Teleflex for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
admin
-
January 8, 2020
0
Latest Pharma-News
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
admin
-
January 8, 2020
0
Latest Pharma-News
BAVENCIO (avelumab) extensively Improved Overall Survival in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
admin
-
January 8, 2020
0
Latest Pharma-News
FDA approved AstraZeneca’s Farxiga(dapagliflozin) for Priority Review for the patients with heart failure with reduced ejection fraction
admin
-
January 8, 2020
0
1
...
134
135
136
...
145
Page 135 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025